Independent Advisor, Private Equity
Brian Hargreaves is an independent advisor to Private Equity.
His career in Healthcare spans academia, Pharma, Venture Capital and Private Equity. Following his early career as a Lecturer in Pharmacy at Manchester University, he had a series of commercial and international marketing roles with Smith Kline and French, Mundipharma, Wellcome, Glaxo Wellcome and with Astra Hässle where he led the commercialisation of the blockbuster product, Nexium. In 1997, he moved to 3i plc in the innovative growth period of biotech Venture Capital. More lately he originated several significant Growth Capital and Buyouts deals.
He currently advises selected Private Equity firms and spends a proportion of his time in the charity sector. He joined the Board of OBN in August 2016.